Discharge Disposition After Stroke in Patients With Liver Disease

Neal S Parikh1, Alexander E Merkler2, Yecheskel Schneider2

  • 1From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute (N.S.P., A.E.M., B.B.N., H.K.), Department of Neurology (N.S.P., A.E.M., B.B.N., H.K.), and Division of Gastroenterology and Hepatology (Y.S.), Weill Cornell Medicine, New York, NY. nsp2001@nyp.org.

Stroke
|December 15, 2016
PubMed

Insights

Patients with liver disease face worse outcomes after stroke, including poorer discharge disposition and higher in-hospital mortality rates for both hemorrhagic and ischemic stroke types.

Area of Science:

  • Neurology
  • Hepatology
  • Public Health

Background:

  • Liver disease is linked to bleeding and clotting issues, increasing intracranial hemorrhage risk.
  • Understanding liver disease impact on stroke outcomes is crucial for patient care.

Purpose of the Study:

  • To assess the association between liver disease and stroke outcomes, specifically discharge disposition.
  • To analyze the impact of liver disease on in-hospital mortality following stroke.

Main Methods:

  • Utilized administrative claims data from California, Florida, and New York (2005-2013).
  • Identified patients hospitalized with stroke, with liver disease as the predictor variable.
  • Employed ordinal and logistic regression, adjusting for demographics, vascular risk factors, and comorbidities.

Main Results:

  • Liver disease was present in 1.7% of over 825,000 stroke patients.
  • Liver disease correlated with worse discharge disposition for both intracerebral hemorrhage (OR 1.28) and ischemic stroke (OR 1.23).
  • Liver disease significantly increased in-hospital mortality risk for intracerebral hemorrhage (OR 1.33) and ischemic stroke (OR 1.60).

Conclusions:

  • Liver disease is associated with adverse hospital discharge outcomes post-stroke.
  • The findings suggest poorer functional outcomes for stroke patients with liver disease.
  • Liver disease presence indicates a higher risk of in-hospital mortality after stroke.
Abstract

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
703
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
305
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
246
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
320
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
274
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
341